(Q37774629)

23 August 2017

1 reference

title

The expanding significance of hypothalamic peptides, or, is endocrinology a branch of neuroendocrinology? (English)

1 reference

23 August 2017

1 reference

R. Guillemin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20649

19 March 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20649

19 March 2022

publication date

1 January 1976

1 reference

23 August 2017

1 reference

23 August 2017

volume

33

1 reference

23 August 2017

page(s)

1-28

1 reference

Glucagon control of fasting glucose in man.

23 August 2017

cites work

1

2

974

Alford

1974

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Impairment of platelet function by growth-hormone release-inhibiting hormone

19 March 2022

3

1

1166

Besser

1975

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Endorphins: Profound Behavioral Effects in Rats Suggest New Etiological Factors in Mental Illness

19 March 2022

4

194

630

Bloom

1976

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

C fragment of lipotropin has a high affinity for brain opiate receptors

19 March 2022

7

260

793

Bradbury

1976

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

19 March 2022

8

179

77

Brazeau

1973

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Somatostatin analogs with selected biologic activities

19 March 2022

9

25

1501

Brown

1976

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin

19 March 2022

13

73

1821

Cox

1976

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas

19 March 2022

14

72

1340

Dubois

1975

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Some analogs of luteinizing hormone releasing hormone (LH-RH) having intense ovulation-inducing activity

19 March 2022

17

57

1248

Fujino

0 references

Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

18

291

544

Gerich

1974

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Evidence for a physiologic role of pancreatic glucagon in human glucose homeostasis: Studies with somatostatin

19 March 2022

19

24

175

Gerich

1975

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Responses of primate spinothalamic tract neurons to natural stimulation of hindlimb.

19 March 2022

20

37

358

Gettings

1974

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Control of corticotrophin release: further studies with in vitro methods.

19 March 2022

21

60

488

Guillemin

1957

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Somatostatin: physiological and clinical significance

19 March 2022

22

27

379

Guillemin

1976

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Identification of two related pentapeptides from the brain with potent opiate agonist activity

19 March 2022

25

258

577

Hughes

1975

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Purification and properties of enkephalin — The possible endogenous ligand for the morphine receptor

19 March 2022

26

16

1753

Hughes

1975

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Delay of puberty and inhibition of reproductive processes in the rat by a gonadotropin-releasing hormone agonist analog

19 March 2022

27

27

853

Johnson

1976

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Effects of somatostatin on hemostasis in baboons

19 March 2022

28

293

476

Koerker

1975

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins

19 March 2022

30

73

2156

Lazarus

1976

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands

19 March 2022

31

73

1145

Li

1976

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Solid phase synthesis of porcine alpha-endorphin and gamma-endorphin, two hypothalamic-pituitary peptides with opiate activity

19 March 2022

32

74

248

Ling

1977

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Failure of somatostatin to inhibit tolbutamide-induced insulin secretion in patients with insulinomas: a possible diagnostic tool

19 March 2022

33

40

1121

Lorenzi

0 references

Inactivation of somatostatin (GH‐RIH) and its analogs by crude and partially purified rat brain extracts

35

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Neurobiology: researchers high on endogenous opiates

19 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

The effect of somatostatin on coagulation and platelet function in man

19 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Synthetic analogs of the hypothalamic luteinizing hormone releasing factor with increased agonist or antatonist properties

19 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.

19 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

An endogenous morphine-like factor in mammalian brain

19 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Common cytochemical and ultrastructural characteristics of cells producing polypeptide hormones (the APUD series) and their relevance to thyroid and ultimobranchial C cells and calcitonin

19 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Neuroendocrine embryology and the APUD concept

19 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Vasoactive Intestinal Polypeptide: Abundant Immunoreactivity in Neural Cell Lines and Normal Nervous Tissue

19 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Structure activity studies on somatostatin

19 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Electrotonic processing of information by brain cells / Francis O. Schmitt, Parvati Dev and Barry H. Smith. - (1976)

19 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Noradrenergic stimulation of cyclic adenosine monophosphate in rat Purkinje neurons: an immunocytochemical study

19 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Morphine-like ligand for opiate receptors in human CSF

19 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

A peptide-like substance from pituitary that acts like morphine. I. Isolation.

19 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Synthetic TRF (thyrotropin releasing factor) analogues. II. pGlu-N3imMe-His-Pro-NH2: a synthetic analogue with specific activity greater than that of TRF2.

19 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Synthetic Polypeptide Antagonists of the Hypothalamic Luteinizing Hormone Releasing Factor

19 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Pharmacology of hypothalamic regulatory peptides

19 October 2022

56

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

An in Vivo Assay for Anti-LH-RH and Anti-FSH-RH Activity of Inhibitory Analogues of LH-RH∗

19 October 2022

57

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

An unidentified depressor substance in certain tissue extracts

19 October 2022

58

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

Synthesis of a Pentekontapeptide with High Lipolytic Activity Corresponding to the Carboxyl-Terminal Fifty Amino Acids of Ovine β-Lipotropin

19 October 2022

59

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-571133-3.50008-8

19 October 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20649

19 October 2022

1 reference